SicuteriF, FranchiG, Del BiancoPL. An Antaminic drug, BC 105, in the prophylaxis of migraine. Int Arch Allergy1967; 31: 78–93.
2.
DrillischC, GirkeW, Ergebnisse de Behandlung von Migräne-Patienten mit Cinnarizin und Flunarizin. Med Welt1980; 31: 1870–1872
3.
WolffHG. Headache and other Head Pain.New York: Oxford University Press1980 (4th edition; ed. Dalessio DJ)
4.
OlesenJ, LarsenB, LauritzenM. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol1981; 9: 344–352
5.
LauritzenM, OlsenTS, LassenNA, PaulsonOB. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol1983; 13: 633–641
6.
MilnerPM. Note on a possible correspondence between the scotomas of migraine and spreading depression of Leao. EEG Clin Neurophysiol1958; 10: 705
7.
WauquierA, AshtonD, MarrannesR. The effects of flunarizine in experimental models related to the pathogenesis of migraine. Cephalalgia1985; 5 (suppl 2): 120–123
8.
LouisP, SpieringsELH. Comparison of flunarizine (Sibelium) and pizotifen (Sandomigran) in migraine treatment: a double -blind study. Cephalalgia1982; 2: 197–203
9.
WörzR, DrillischC. Migräne-Prophylaxe durch einen Kalziumeintritsblocker. Ergebnisse einer Doppelblindstudie Flunarizin vs. Pizotifen. Münch Med Wschr1983; 125: 711–714
10.
D'EttorreM, BattistaV, MorettiL, RaimondiS, FedericoA. Trattamento della cefalea accessionale. Studio in doppio cieco con flunarizina e pisotifene. Giornale di Neuropsicofarmacologia1985; 7: 323–327
11.
NuijtenSTM. Comparative trial of flunarizine and pizotifen in the prophylaxis of migraine (abstract). Zschr Neurol1985; 232 (suppl): 219
RascolA, MontastrucJL, RascolO. Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine. Headache1986; 26: 83–85
14.
ZelenM. Biostatistics and the clinical cancer cooperative group program. Cancer. March, 1979 (cited by Mosteller et al)
15.
MostellerF, GilbertJP, McPeekB. Reporting standards and research strategies for controlled trials: agenda for the editor. Controlled Clinical Trials1979; 1: 37–58
